What are the diagnostic criteria for diabetes mellitus?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 1, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Diagnostic Criteria for Diabetes Mellitus

Diabetes mellitus is diagnosed when any one of four criteria is met: A1C ≥6.5%, fasting plasma glucose (FPG) ≥126 mg/dL, 2-hour plasma glucose ≥200 mg/dL during a 75-g oral glucose tolerance test (OGTT), or random plasma glucose ≥200 mg/dL in a patient with classic hyperglycemic symptoms or crisis. 1, 2

Primary Diagnostic Thresholds

The American Diabetes Association establishes four distinct pathways to diagnose diabetes in non-pregnant adults: 1, 2

  • A1C ≥6.5% (≥48 mmol/mol) performed in a laboratory using a method certified by the National Glycohemoglobin Standardization Program (NGSP) and standardized to the Diabetes Control and Complications Trial (DCCT) assay 1, 2

  • Fasting Plasma Glucose (FPG) ≥126 mg/dL (≥7.0 mmol/L), where fasting is defined as no caloric intake for at least 8 hours 1, 2

  • 2-hour Plasma Glucose ≥200 mg/dL (≥11.1 mmol/L) during a 75-g OGTT performed as described by the World Health Organization 1, 2

  • Random Plasma Glucose ≥200 mg/dL (≥11.1 mmol/L) in an individual with classic symptoms of hyperglycemia (polyuria, polydipsia, unexplained weight loss) or hyperglycemic crisis (diabetic ketoacidosis or hyperglycemic hyperosmolar state) 1, 3

Confirmation Requirements: The Critical Two-Test Rule

In the absence of unequivocal hyperglycemia (hyperglycemic crisis with symptoms), diagnosis requires two abnormal test results. 1, 2 This is where many clinicians make errors, so understanding the confirmation algorithm is essential:

When Confirmation is Required:

  • Any single abnormal test result in an asymptomatic patient or patient without hyperglycemic crisis must be confirmed 1, 2
  • Confirmation can be achieved by repeating the same test on a different day 1
  • Alternatively, two different tests (e.g., A1C and FPG) performed on the same sample, both above diagnostic thresholds, confirm the diagnosis 1

When Confirmation is NOT Required:

  • A patient presenting with classic symptoms of hyperglycemia (polyuria, polydipsia, weight loss) or hyperglycemic crisis AND random plasma glucose ≥200 mg/dL requires no confirmatory testing 1, 3

Managing Discordant Results:

When two different tests yield conflicting results (one above, one below diagnostic threshold): 1

  • Repeat the test that was above the diagnostic threshold 1
  • If the repeated test remains elevated, diagnose diabetes based on the confirmed abnormal test 1
  • If a patient has A1C ≥6.5% confirmed on repeat testing but FPG <126 mg/dL, that person still has diabetes 1

Test Selection: Practical Considerations

FPG is the preferred test in most clinical settings due to ease of administration, convenience, patient acceptability, and lower cost compared to OGTT. 2 However, the three tests (A1C, FPG, 2-hour PG) reflect different aspects of glucose metabolism and have incomplete concordance—they do not identify diabetes in the same individuals. 1, 3

The 2-hour plasma glucose during OGTT diagnoses more people with diabetes and prediabetes compared to FPG and A1C cut points. 1 This is particularly relevant in populations where post-prandial hyperglycemia predominates.

Critical Limitations of A1C Testing

A1C should NOT be used for diagnosis in the following conditions affecting red blood cell turnover: 2, 3

  • Hemoglobinopathies (sickle cell disease, thalassemia) 1, 2
  • Hemolytic anemias 2, 3
  • Pregnancy 2, 3
  • Recent blood loss or blood transfusion 2, 3
  • Hemodialysis 2, 3
  • Erythropoietin therapy 2, 3

In these conditions, only plasma glucose criteria (FPG, 2-hour PG, or random glucose) should be used for diagnosis. 2, 3 For patients with abnormal hemoglobins but normal red cell turnover (such as sickle cell trait), use an A1C assay without interference from abnormal hemoglobins. 1

Point-of-Care A1C Testing Caution:

While point-of-care A1C assays may be used in CLIA-certified settings meeting quality standards, caution is advised when using them for diagnosis—they are better suited for monitoring glycemic control. 2 Diagnostic A1C testing should be performed in accredited laboratories using venous plasma. 3

Prediabetes Categories: Identifying High-Risk Individuals

The American Diabetes Association recognizes three categories of increased risk for diabetes (prediabetes): 1

  • Impaired Fasting Glucose (IFG): FPG 100-125 mg/dL (5.6-6.9 mmol/L) 1, 2
  • Impaired Glucose Tolerance (IGT): 2-hour PG 140-199 mg/dL (7.8-11.0 mmol/L) during 75-g OGTT 1, 2
  • A1C: 5.7-6.4% 1, 2

For all three prediabetes categories, risk is continuous and becomes disproportionately greater at the higher ends of the range. 1

Common Pitfalls and How to Avoid Them

Pitfall #1: Using Capillary Blood Glucose for Diagnosis

Never use capillary blood glucose testing as a stand-alone diagnostic test—it performs poorly for diagnosis with high specificity (92-98%) but low sensitivity (39-55%). 2 All diagnostic testing must be performed using venous plasma in accredited laboratories. 3

Pitfall #2: Ignoring Test Variability

Due to preanalytic and analytic variability, when a test above the diagnostic threshold is repeated, the second value may fall below the cut point. 1 This is least likely for A1C, somewhat more likely for FPG, and most likely for 2-hour PG. 1 Such patients likely have results near diagnostic margins—consider close follow-up and repeat testing in 3-6 months. 1

Pitfall #3: Lower Sensitivity of A1C

The A1C cut point of ≥6.5% identifies approximately one-third fewer cases of undiagnosed diabetes compared to FPG ≥126 mg/dL when applied to population screening. 1 However, the greater practicality and convenience of A1C may increase the actual number of diagnoses made in real-world practice. 1

Pitfall #4: Rapidly Evolving Diabetes

In rapidly evolving diabetes, such as new-onset type 1 diabetes in children, A1C may not be significantly elevated despite frank hyperglycemia. 1 In these cases, rely on plasma glucose criteria for diagnosis.

Screening Recommendations

Testing should be considered in: 1

  • All adults aged 45 years and older, with repeat testing at minimum 3-year intervals if normal 1, 3
  • Overweight or obese adults (BMI ≥25 kg/m² or ≥23 kg/m² in Asian Americans) with one or more additional risk factors at any age 1
  • Adults with sustained blood pressure >135/80 mmHg 3

Additional risk factors include: physical inactivity, first-degree relative with diabetes, high-risk ethnicity (African American, Latino, Native American, Asian American, Pacific Islander), history of gestational diabetes or delivering a baby >9 lb, hypertension (≥140/90 mmHg or on therapy), HDL cholesterol <35 mg/dL and/or triglycerides >250 mg/dL, polycystic ovary syndrome, previous A1C ≥5.7%, and history of cardiovascular disease. 1, 3

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Diagnostic Criteria for Type 2 Diabetes Mellitus

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Diagnosing Diabetes Mellitus

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Related Questions

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.